Corey Horien

Jan 17, 2025 | medrxiv.org | Corey Horien |Francesca Mandino |Abigail Greene |Xilin Shen

James C. McPartland consults or has consulted with Customer Value Partners, Bridgebio, Determined Health, Apple, and BlackThorn Therapeutics, has received research funding from Janssen Research and Development, serves on the Scientific Advisory Boards of Pastorus and Modern Clinics, and receives royalties from Guilford Press, Lambert, Oxford, and Springer. This work was supported by the National Institutes of Health (P50MH115716, T32GM007205 to CH and ASG, and TR001864 to ASG).